2021 annual financial data
Vistagen Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -1,108.17%.
Operating income was -17,933,800 USD and net income was -17,934,200 USD.
Operating cash flow was -12,073,500 USD.
Get free Vistagen Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,089,500 USD
- Operating income
- -17,933,800 USD
- Net income
- -17,934,200 USD
- Operating cash flow
- -12,073,500 USD